Skip to main content
TipRanks
Go Ultimate75% OFF

Meiragtx Holdings (MGTX) Drug Pipeline

540 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Aav2-Haqp1Grade 2 And 3 Late Xerostomia Caused By Radiotherapy For Cancers Of The Upper Aerodigestive Tract, Excluding The Parotid GlandsPhase IIEnrolling By InvitationLong-term Follow-up of Gene Therapy for Radiation-Induced XerostomiaAug 05, 2024―
Aav2-Haqp1 Concentration 1, Aav2-Haqp1 Concentration 2, Aav2-Haqp1 Concentration 3, Aav2-Haqp1 Concentration 4Grade 2 And 3 Late Xerostomia Caused By Radiotherapy For Cancers Of The Upper Aerodigestive Tract, Excluding The Parotid GlandsPhase IIRecruitingA Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late XerostomiaJun 22, 2023―
Aav-GadParkinson's Diseasephase1AndPhase2Active Not RecruitingLong-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's DiseaseMay 30, 2023―
Aav-Gad Low Dose, Aav-Gad High Dose, Sham SurgeryParkinson's Diseasephase1AndPhase2CompletedA Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's ParticipantsOct 12, 2022―
Aav2haqp1Squamous Cell Head And Neck Cancer, Radiation Induced Xerostomia, Salivary HypofunctionPhase IActive Not RecruitingSafety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary HypofunctionMay 14, 2015―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Meiragtx Holdings (MGTX) have in its pipeline
Meiragtx Holdings MGTX is currently developing the following drugs: Aav2-Haqp1, Aav2-Haqp1 Concentration 1, Aav2-Haqp1 Concentration 2, Aav2-Haqp1 Concentration 3, Aav2-Haqp1 Concentration 4, Aav-Gad, Aav-Gad Low Dose, Aav-Gad High Dose, Sham Surgery, Aav2haqp1. These drug candidates are in various stages of clinical development as the company works toward FDA approval.